Recent Event Highlights: Cytori Therapeutics at the 2010 onemedforum, Cytori Therapeutics (NASDAQ:CYTX) Stock Trading Idea: 113.5% Return in 4 Months, Cytori Therapeutics (NASDAQ:CYTX) Stock Trading Idea: 56% Return in 3 Months, 4-Star Stocks Poised to Pop: Cytori Therapeutics, Cytori Therapeutics, CEO Christopher Calhoun, Cytori Comments on Patent Appeal, and 8 more...
Created by dipity on Mar 22, 2010
Last updated: 03/22/10 at 05:10 AM
Cytori has no followers yet. Be the first one to follow.
2010-02-24 19:43:02 - Cytori Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
device company, engaged in the development and commercialization of stem and
onemedtv captures Chris Calhoun, CEO of Cytori Therapeutics, at the 2010 onemedforum in San Francisco. onemedtv is the video production department of onemedplace, a research and media services firm in the healthcare and life sciences field with a focus on emerging companies. Please visit www.onemedplace.com for more information on all our products and services.
smartrend identified an Uptrend for Cytori Therapeutics (NASDAQ:CYTX) on September 23, 2009 at $4.00. In approximately 4 months, Cytori Therapeuticshas returned 113.5% as of today's recent price of $8.54. Cytori Therapeutics is currently above its 50-day moving average of $5.99 and above its 200-day moving average of $3.93. Look for these moving averages to climb to confirm the company's upward momentum. smartrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Cytori Therapeutics shares.
Mega Volume Fat Grafting (breasts, buttocks) demands an efficient procedure. Mega Volume Grafting requires Mega Volume Processing. With the patented gentlespin Centifuge, almost 500 cc of fat can be processed in three minutes, making fat grafting simpler and less time consuming, In addition, the low speed low G-force centrifugation is likely to be less traumatic to cells.
01/13/10 - www.thetechtrader.com - Old favorite Coverted Organics (COIN), which has gotten decimated this year, dropped all the way down from 17 a year a half, almost two years ago, to under a 1.00. Recently this stock had run from .57 up to 1.27. Today, in particular though, we're pointing it out because 24 million shares traded breaking out above it's lateral price resistance and this stock gets across todays high of 1.27. infospace (INSP), which a couple days ago was highlighted and day traded, is up .39 or 3.5% with an increasing volume. It's at 11.47, but if it takes out 12.15 it could explode into 14-14.50, maybe even 15 short-term. It's had a line of resistance for 3 years, but if it can get through that it could go up towards the high teens. Skechers USA (SKX), which apparently is selling their new shoe like hotcakes, has been in a monster move all year going from 5.20 last March to today's closing at 30.95, and appears to be wanting to go even higher. Next target is up around 36. Xyratex (XRTX) closed up 1.79 or 12% on the heaviest volume in awhile. It could do a mid-channel test up around the 19.50-20 zone. Beyond that possibly high 20s, but there may be some lateral resistance around the 25 area. Those along with some of the other stocks on Harry's Chart of the Day today are good ones to keep your eye on. Be sure to listen to the video and get details on Amtech Systems (ASYS), China Agritech (CAGC), Continucare (CNU), Cytori Therapeutics (CYTX), Green Plains ...
smartrend alerted subscribers to an Uptrend for Cytori Therapeutics (NASDAQ:CYTX) on September 23, 2009 at $4.00. In less than 3 months, Cytori Therapeutics has returned 56% as of December 10ths closing price of $6.24.
...(NYSE: GE)]. In a pitch from two days ago, mrindependent also helped Fools follow the Cytori story. Here's an excerpt: Cytori makes products focused on the extraction of stem cells from body fat cells, reconstitution of the cells in a proprietary machine,...
The Money Times
Cytori Therapeutics CEO Christopher Calhoun discusses his firm's research in regenerative medicine.onemedtv is the video production department of onemedplace, a research and media services firm in the healthcare and life sciences field with a focus on emerging companies. Please visit www.onemedplace.com for more information on all our products and services.
...press release. Investor Contact:Cytori TherapeuticsTom Baker, 858-875-5258 firstname.lastname@example.org : mailto:email@example.com Cytori Therapeutics (NASDAQ:CYTX) has been informed that the United States Federal Court in the Central District of California upheld...
Le 9 fasi per la preparazione, il trattamento del tessuto adiposo ed esecuzione dell'intervento (www.nicecare.it)
Animazione rimodellamento seno con lipofilling e cellule staminali (www.nicecare.it)
Cytori Therapeutics, J. Crew, LHC Group, Oriental Financial Group, and more.
2008-06-09 13:43:31 -
concept of a bedside device to deliver a patient's own adipose derived stem and regenerative cells in a single procedure," said Marc H. Hedrick, M.D., president of Cytori and named inventor on this patent. "We believe
...was published by mistake," and he notes that the magazine is working with Cytori on an in-depth follow-up piece about the Cytori system that will clarify matters. The quickie boob-boost story, though, didn’t just raise more hopes than bra sizes. It overshadowed...
... LOS ANGELES (Reuters) - Cytori Therapeutics Inc. said on Thursday that it will begin the first clinical trial to test whether stem cells derived from fat can be used to regenerate breast tissue in Japan next month. The 20-patient study, which will...